<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0177521</article-id>
<article-id pub-id-type="publisher-id">PONE-D-17-00449</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Cardiology</subject><subj-group><subject>Myocardial infarction</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Infarction</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Infarction</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Cardiovascular anatomy</subject><subj-group><subject>Heart</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Cardiovascular anatomy</subject><subj-group><subject>Heart</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Oxidative stress</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Antioxidants</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Energy metabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological processes</subject><subj-group><subject>Energy metabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological processes</subject><subj-group><subject>Energy metabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological parameters</subject><subj-group><subject>Body weight</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological parameters</subject><subj-group><subject>Body weight</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Enzymology</subject><subj-group><subject>Enzymes</subject><subj-group><subject>Dismutases</subject><subj-group><subject>Superoxide dismutase</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Enzymes</subject><subj-group><subject>Dismutases</subject><subj-group><subject>Superoxide dismutase</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Rosemary supplementation (<italic>Rosmarinus oficinallis</italic> L.) attenuates cardiac remodeling after myocardial infarction in rats</article-title>
<alt-title alt-title-type="running-head">Rosemary supplementation attenuates cardiac remodeling</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8825-6980</contrib-id>
<name name-style="western">
<surname>Murino Rafacho</surname>
<given-names>Bruna Paola</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Portugal dos Santos</surname>
<given-names>Priscila</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Gonçalves</surname>
<given-names>Andréa de Freitas</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Fernandes</surname>
<given-names>Ana Angélica Henrique</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Okoshi</surname>
<given-names>Katashi</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Chiuso-Minicucci</surname>
<given-names>Fernanda</given-names>
</name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="fn" rid="currentaff001"><sup>¤</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Azevedo</surname>
<given-names>Paula S.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Mamede Zornoff</surname>
<given-names>Leonardo Antonio</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Minicucci</surname>
<given-names>Marcos Ferreira</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Wang</surname>
<given-names>Xiang-Dong</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Rupp de Paiva</surname>
<given-names>Sergio Alberto</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Internal Medicine Department, Botucatu Medical School–UNESP, Botucatu/SP, Brazil</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Biochemistry, Botucatu Biosciences Institute–UNESP, Botucatu/SP, Brazil</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Department of Microbiology and Immunology, Botucatu Biosciences Institute–UNESP, Botucatu/SP, Brazil</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Nutrition and Cancer Biology Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston/MA, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Lionetti</surname>
<given-names>Vincenzo</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Scuola Superiore Sant'Anna, ITALY</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple"> <list-item>
<p><bold>Conceptualization:</bold> BPMR SARP.</p></list-item> <list-item>
<p><bold>Data curation:</bold> BPMR.</p></list-item> <list-item>
<p><bold>Formal analysis:</bold> BPMR MFM SARP.</p></list-item> <list-item>
<p><bold>Funding acquisition:</bold> SARP BPMR.</p></list-item> <list-item>
<p><bold>Investigation:</bold> BPMR PPS AFG FCM AAHF KO.</p></list-item> <list-item>
<p><bold>Methodology:</bold> SARP MMF LAMZ PSA KO.</p></list-item> <list-item>
<p><bold>Project administration:</bold> SARP.</p></list-item> <list-item>
<p><bold>Resources:</bold> SARP MFM LAMZ PSA.</p></list-item> <list-item>
<p><bold>Supervision:</bold> SARP MFM.</p></list-item> <list-item>
<p><bold>Validation:</bold> LAMZ PSA MFM SARP.</p></list-item> <list-item>
<p><bold>Visualization:</bold> BPMR SARP.</p></list-item> <list-item>
<p><bold>Writing – original draft:</bold> BPMR SARP.</p></list-item> <list-item>
<p><bold>Writing – review &amp; editing:</bold> SARP XDW.</p></list-item></list>
</p>
</fn>
<fn fn-type="current-aff" id="currentaff001">
<label>¤</label>
<p>Current address: Internal Medicine Department, Botucatu Medical School–UNESP, Botucatu/SP, Brazil.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">bpmrafacho@alunos.fmb.unesp.br</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>12</volume>
<issue>5</issue>
<elocation-id>e0177521</elocation-id>
<history>
<date date-type="received">
<day>4</day>
<month>1</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>4</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Murino Rafacho et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0177521"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>Myocardial infarction (MI) is one of the leading causes of morbidity and mortality worldwide. Dietary intervention on adverse cardiac remodeling after MI has significant clinical relevance. Rosemary leaves are a natural product with antioxidant/anti-inflammatory properties, but its effect on morphology and ventricular function after MI is unknown.</p>
</sec>
<sec id="sec002">
<title>Methods and results</title>
<p>To determine the effect of the dietary supplementation of rosemary leaves on cardiac remodeling after MI, male Wistar rats were divided into 6 groups after sham procedure or experimental induced MI: 1) Sham group fed standard chow (SR0, n = 23); 2) Sham group fed standard chow supplemented with 0.02% rosemary (R002) (SR002, n = 23); 3) Sham group fed standard chow supplemented with 0.2% rosemary (R02) (SR02, n = 22); 4) group submitted to MI and fed standard chow (IR0, n = 13); 5) group submitted to MI and fed standard chow supplemented with R002 (IR002, n = 8); and 6) group submitted to MI and fed standard chow supplemented with R02 (IR02, n = 9). After 3 months of the treatment, systolic pressure evaluation, echocardiography and euthanasia were performed. Left ventricular samples were evaluated for: fibrosis, cytokine levels, apoptosis, energy metabolism enzymes, and oxidative stress. Rosemary dietary supplementation attenuated cardiac remodeling by improving energy metabolism and decreasing oxidative stress. Rosemary supplementation of 0.02% improved diastolic function and reduced hypertrophy after MI. Regarding rosemary dose, 0.02% and 0.2% for rats are equivalent to 11 mg and 110 mg for humans, respectively.</p>
</sec>
<sec id="sec003">
<title>Conclusion</title>
<p>Our findings support further investigations of the rosemary use as adjuvant therapy in adverse cardiac remodeling.</p>
</sec>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001807</institution-id>
<institution>Fundação de Amparo à Pesquisa do Estado de São Paulo</institution>
</institution-wrap>
</funding-source>
<award-id>2011/08956</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8825-6980</contrib-id>
<name name-style="western">
<surname>Murino Rafacho</surname>
<given-names>Bruna Paola</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001807</institution-id>
<institution>Fundação de Amparo à Pesquisa do Estado de São Paulo</institution>
</institution-wrap>
</funding-source>
<award-id>2011/15059-5</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Rupp de Paiva</surname>
<given-names>Sergio Alberto</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003593</institution-id>
<institution>Conselho Nacional de Desenvolvimento Científico e Tecnológico</institution>
</institution-wrap>
</funding-source>
<award-id>140262/2011-3</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8825-6980</contrib-id>
<name name-style="western">
<surname>Murino Rafacho</surname>
<given-names>Bruna Paola</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This work was funded by National Council of Technological and Scientific Development (CNPq 140262/2011-3) and São Paulo Research Foundation (FAPESP 2011/08956-0 and 2011/15059-5), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="6"/>
<table-count count="1"/>
<page-count count="17"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec004" sec-type="intro">
<title>Introduction</title>
<p>Myocardial infarction (MI) is one of the leading causes of morbidity and mortality worldwide. According to the 2015 update of A Report From the American Heart Association, approximately 635,000 Americans have a new coronary attack each year[<xref ref-type="bibr" rid="pone.0177521.ref001">1</xref>]. MI can be defined as a focus of necrosis resulting from poor tissue perfusion, with signs and symptoms resulting from cardiac cell death. The death of myocytes initiates a cascade of intracellular signaling, such as inflammation, oxidative stress, reabsorption of necrotic tissue, excessive deposition of collagen, and hypertrophy, that can result in adverse cardiac remodeling. These molecular, cellular and interstitial changes can clinically be manifested as changes in size, mass, geometry and heart function. Cardiac remodeling is an adaptation of the heart to aggression stimuli that may gradually lead to the development of heart failure (HF), responsible for the increased mortality after MI[<xref ref-type="bibr" rid="pone.0177521.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0177521.ref003">3</xref>].</p>
<p>Many factors can participate on MI pathophysiology. MI is started by myocardial ischemia and it is associated with increased generation of reactive oxygen species (ROS)[<xref ref-type="bibr" rid="pone.0177521.ref004">4</xref>]. In experimental studies, oxidative stress is identified as a major factor for the development of cardiac hypertrophy[<xref ref-type="bibr" rid="pone.0177521.ref005">5</xref>]. Oxidative stress can also activate the production of inflammatory cytokines such as tumor necrosis factor-α (TNF-α), IL-1β and IL-6[<xref ref-type="bibr" rid="pone.0177521.ref006">6</xref>], triggering inflammatory pathways, fibrosis and cell death[<xref ref-type="bibr" rid="pone.0177521.ref005">5</xref>]. ROS and cytokines also contribute to the activation of matrix metalloproteinases (MMPs) and collagen deposition that might lead to structural changes in the heart [<xref ref-type="bibr" rid="pone.0177521.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0177521.ref007">7</xref>].</p>
<p>Because oxidative stress can play a central pathophysiological role in cardiac remodeling after MI[<xref ref-type="bibr" rid="pone.0177521.ref004">4</xref>, <xref ref-type="bibr" rid="pone.0177521.ref007">7</xref>], antioxidant supplements are beneficial after injury to the myocardium[<xref ref-type="bibr" rid="pone.0177521.ref008">8</xref>, <xref ref-type="bibr" rid="pone.0177521.ref009">9</xref>]. In this context, the antioxidant properties of natural products have been examined[<xref ref-type="bibr" rid="pone.0177521.ref010">10</xref>]. Rosemary (<italic>Rosmarinus oficinallis</italic> Linn) is a popular culinary spice, but it is also known as a medicinal herb and a natural conservative in the food industry, with one of the highest levels of antioxidant compounds[<xref ref-type="bibr" rid="pone.0177521.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0177521.ref012">12</xref>]. Many compounds have been isolated from rosemary, including flavones and diterpenes. The phenolic diterpenes carnosic acid and carnosol are the major bioactive compounds in rosemary leaves related to the antioxidant activity [<xref ref-type="bibr" rid="pone.0177521.ref012">12</xref>, <xref ref-type="bibr" rid="pone.0177521.ref013">13</xref>]. Rosmarinic acid is a caffeic acid ester with antioxidant and anti-inflammatory activity[<xref ref-type="bibr" rid="pone.0177521.ref014">14</xref>, <xref ref-type="bibr" rid="pone.0177521.ref015">15</xref>]. <italic>In vitro</italic> studies described that rosemary compounds suppressed IL-β and TNF-α, and increased glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) activity in different models[<xref ref-type="bibr" rid="pone.0177521.ref016">16</xref>–<xref ref-type="bibr" rid="pone.0177521.ref018">18</xref>]. <italic>In vivo</italic>, rosemary extract supplementation improved the oxidative stress status in the heart of aged rats[<xref ref-type="bibr" rid="pone.0177521.ref019">19</xref>, <xref ref-type="bibr" rid="pone.0177521.ref020">20</xref>]. Furthermore, rosmarinic acid reduced myocardial damage blood pressure in hypertensive rats fed a high fructose diet[<xref ref-type="bibr" rid="pone.0177521.ref015">15</xref>] and protected the heart against cardiac dysfunction and fibrosis after MI in rats[<xref ref-type="bibr" rid="pone.0177521.ref021">21</xref>]. However, little is known about the effect of rosemary leaves intake in morphology and ventricular function after myocardial injury. To our knowledge, the protective potential of rosemary has predominantly been studied in rosemary extract and/or its constituents, and information about rosemary intake as a whole food is limited. Evidence shows that focusing on an approach based on foods and dietary patterns instead of individual nutrients improves cardiometabolic health[<xref ref-type="bibr" rid="pone.0177521.ref022">22</xref>, <xref ref-type="bibr" rid="pone.0177521.ref023">23</xref>]. Thus, the aim of the present study was to evaluate the effect of rosemary leaves dietary supplementation on cardiac remodeling after myocardial infarction.</p>
</sec>
<sec id="sec005" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec006">
<title>Study design</title>
<p>All experiments and procedures were performed in accordance with the National Institute of Health’s Guide for the Care and Use of Laboratory Animals and with the Ethical Principles in Animal Experimentation adopted by the Brazilian College of Animal Experimentation[<xref ref-type="bibr" rid="pone.0177521.ref024">24</xref>]. The study protocol (838/10) was submitted and approved by the Botucatu Medical School Animal Research Ethics Committee.</p>
<p>Male Wistar rats weighing 200 to 250 g were used in this study. MI was conducted by coronary artery ligation, as previously described[<xref ref-type="bibr" rid="pone.0177521.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0177521.ref025">25</xref>]. In brief, rats were anesthetized with ketamine (70 mg/kg) and xylazine (1 mg/kg), and after left thoracotomy, the heart was exteriorized by lateral compression of the thorax. The left atrium was retracted to facilitate ligation of the left coronary artery with wired polyvinyl (5–0 Ethicon). The left coronary artery was ligated approximately 2 mm between the border of the left atrium and the pulmonary outflow tract. The heart was then replaced in the thorax, the lungs were inflated by positive pressure, and thoracotomy closed. A sham group, in which animals were submitted to surgery but without coronary occlusion, was also created. After surgery rats were housed in a temperature-controlled room (24°C) with a 12-h light/12-h dark cycle. Water and food was supplied <italic>ad libitum</italic> after the procedure.</p>
<p>Two days after surgery, survivors were assigned to one of the six groups: 1) group SR0, sham animals fed standard chow only (n = 23); 2) group SR002, sham animals fed standard chow with 0.02% of rosemary leaves (n = 23); 3) group SR02, sham animals fed standard chow with 0.2% of rosemary leaves (n = 22); 4) IR0, infarcted animals fed standard chow only (n = 13); 5) IR002, infarcted animals fed standard chow with 0.02% of rosemary leaves (n = 8); and 6) IR02, infarcted animals fed standard chow with 0.2% of rosemary leaves (n = 9) (<xref ref-type="fig" rid="pone.0177521.g001">Fig 1</xref>). Treatment began 48 h after surgery because during this period mortality may be related to bleeding, pneumothorax, and anesthesia rather than to the infarction or treatment. Rosemary supplementation was provided for 90 days.</p>
<fig id="pone.0177521.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0177521.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Study design.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0177521.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec007">
<title>Rosemary supplementation</title>
<p>Nuvilab chow (Nuvital®) was used for all experiments. Chow was initially chopped for the later addition of rosemary leaves. Fresh rosemary leaves were purchased in 2011 from Companhia de Entrepostos e Armazéns Gerais de São Paulo (CEAGESP), state of São Paulo, Brazil and were identified by a trained dietitian. The leaves were oven dried for 48 hours at a temperature of 50°C, ground in a domestic mixer (Walita, São Paulo, Brazil) for 30 seconds, and sieved using sieves of the Standard Tyler 32 (Bertel Industries, São Paulo, Brazil). Ground particles were stored under vacuum and maintained in a domestic freezer (Brastemp, São Paulo, Brazil) below –10°C. Rosemary powder was added to the crushed chow, and the mixture was pelletized. Food intake of all animals was measured every 24 hours. The mean daily intake for each rat was calculated. Rosemary supplementation doses of 0.02% and 0.2% were chosen based on the study of Posadas et al. (2009)[<xref ref-type="bibr" rid="pone.0177521.ref019">19</xref>].</p>
</sec>
<sec id="sec008">
<title>Measurement of systolic arterial pressure</title>
<p>Systolic arterial pressure measurement was performed 2 weeks (corresponding to 2.5 months of rosemary supplementation) before euthanasia by tail plethysmograph, as described previously[<xref ref-type="bibr" rid="pone.0177521.ref026">26</xref>].</p>
</sec>
<sec id="sec009">
<title>Echocardiographic study</title>
<p>After three months of supplementation, rats were weighed and evaluated by a transthoracic echocardiographic exam, as previously described[<xref ref-type="bibr" rid="pone.0177521.ref027">27</xref>, <xref ref-type="bibr" rid="pone.0177521.ref028">28</xref>]. All measurements were made by the same observer blinded to individual animal treatments and according to the American Society of Echocardiography/European Association of Echocardiography[<xref ref-type="bibr" rid="pone.0177521.ref029">29</xref>].</p>
<p>After the echocardiographic study, the animals were euthanized with large dose of pentobarbital, and their hearts were removed. Left ventricle (LV) was isolated and LV samples were immediately frozen and stored at -80°C. One transverse section of the LV was separated and fixed in 10% buffered formalin and then was embedded in paraffin for histological study.</p>
</sec>
<sec id="sec010">
<title>Morphometric analysis</title>
<p>Five-micrometer-thick sections were stained with hematoxylin and eosin (HE) for cardiomyocyte cross-sectional area (CSA) determination and with Pircrosirius red for Interstitial collagen fraction (ICF) and infarction size calculations. All animals were included in the morphometric analysis. First infarction size was calculated. To calculate infarction size, lengths of the infarcted and the viable muscle for both endocardial and epicardial circumferences were determined by planimetry, and then calculated by dividing endocardial and epicardial circumferences of the infarcted area by total epicardial and endocardial ventricular circumferences[<xref ref-type="bibr" rid="pone.0177521.ref028">28</xref>]. Measurements were performed on midventricular slices (5–6 mm from the apex), under the assumption that the left midventricular slice showed a close linear relation with the sum of the area measurements from all heart slices[<xref ref-type="bibr" rid="pone.0177521.ref030">30</xref>]. After infarction size calculation, infarcted animals with less than 36% of LV infarcted area were excluded of further analysis[<xref ref-type="bibr" rid="pone.0177521.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0177521.ref032">32</xref>]. Minicucci et al. (2011) showed that the infarct size cut-off value to induce cardiac remodeling in rats should be 36% of LV area[<xref ref-type="bibr" rid="pone.0177521.ref031">31</xref>].</p>
<p>The CSA measurements were obtained from at least 40 digital images(400 × magnification) with a digital pad, and the selected cells were transversely cut so that the nucleus was in the center of the myocyte[<xref ref-type="bibr" rid="pone.0177521.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0177521.ref034">34</xref>]. The CSA was considered to evaluate heart hypertrophy. ICF was determined in remote cardiac areas free from MI from at least 20 digital images (400 × magnification).</p>
<p>All images were collected with a video camera attached to a Leica microscope; the images were analyzed with the Image-Pro Plus 3.0 software program (Media Cybernetics; Silver Spring, MD).</p>
</sec>
<sec id="sec011">
<title>Cytokine production</title>
<p>Tumor necrosis factor-α (TNF-α), IFN-γ and IL-10 concentrations in LV samples were determined by ELISA according to the manufacturer’s instructions (R&amp;D Systems, Minneapolis, MN).</p>
</sec>
<sec id="sec012">
<title>MMP-2 and TIMP-1 evaluation</title>
<p>Matrix metalloproteinase (MMP)-2 activity was determined in LV samples by zimography, as previously reported[<xref ref-type="bibr" rid="pone.0177521.ref034">34</xref>, <xref ref-type="bibr" rid="pone.0177521.ref035">35</xref>]. TIMP-1 levels were evaluated by ELISA according to the manufacturer’s instructions (R&amp;D Systems, Minneapolis, MN</p>
</sec>
<sec id="sec013">
<title>Lipid hydroperoxide, antioxidant and energy metabolism enzymes</title>
<p>Eight LV samples of each experimental group were used for measurements of total protein and lipid hydroperoxide (LH) concentration and for enzyme activity determinations. Glutathione peroxidase (GSH-Px, E.C.1.11.1.9), superoxide dismutase (SOD, E.C.1.15.1.1) and catalase (CAT, E.C.1.11.1.6) activity was assessed as previously specified[<xref ref-type="bibr" rid="pone.0177521.ref036">36</xref>, <xref ref-type="bibr" rid="pone.0177521.ref037">37</xref>]. Cardiac energy metabolism was assessed by β-hydroxyacyl coenzyme-A dehydrogenase (OHADH, E.C.1.1.1.35.), lactate dehydrogenase (LDH, E.C.1.1.1.27), citrate synthase (CS; E.C.4.1.3.7.), Complex I (NADH:ubiquinone oxidoreductase), Complex II (succinate dehydrogenase), and ATP synthase (EC 3.6.3.14) activities, as previously described[<xref ref-type="bibr" rid="pone.0177521.ref037">37</xref>, <xref ref-type="bibr" rid="pone.0177521.ref038">38</xref>]. Spectrophotometric determinations were performed with a Pharmacia Biotech spectrophotometer UV/visible Ultrospec 5000 with Swift II Application software (Cambridge, England, UK) at 560 nm. All reagents were purchased from Sigma (St. Louis, Missouri, USA).</p>
</sec>
<sec id="sec014">
<title>Western blot analysis</title>
<p>Briefly, left ventricular samples were extracted using RIPA Buffer to detect heme-oxygenase-1 (HO-1), caspase-3, Bcl2 and peroxisome proliferator-activated receptor-α coactivator (PGC)-1α expression. To determine nuclear erithroid factor 2 (Nrf-2), LV samples were extracted with Nuclear Extraction Buffer[<xref ref-type="bibr" rid="pone.0177521.ref039">39</xref>]. The following primary antibodies were used: HO-1-1 to heme oxygenase-1; ab13248 (Abcam Inc, Cambridge); Nrf2: C-20, rabbit Immunoglobulin G (Santa Cruz Biotechnology Inc, Europe); Cleaved Caspase-3 (Asp175) (5A002E) Rabbit mAb (Cell Signalling Technology Inc., USA); Bcl2 sc 492 IgG rabbit monoclonal (Santa Cruz Biotechnology, Inc, Europe); and PGC-1α Antibody H-300: sc-13067 (Santa Cruz Biotechnology, Inc, Europe). GAPDH (GAPDH (6C5), mouse monoclonal IgG1, (Santa Cruz Biotechnology, Inc., Europe, sc 32233) was used for normalization.</p>
</sec>
<sec id="sec015">
<title>Statistical analysis</title>
<p>Data are presented as the mean±SEM. The results were tested for both normality (Kolmogorov–Smirnov test) and equal variance before statistical analyses, and all data passed these tests. Data were analyzed by 2-factor ANOVA, therefore this analysis gives three p values: 1) factor one: presence of myocardial infarction (I); 2) factor two: rosemary content (R); and 3) interaction between factors I and R. When an interaction was found to be significant, the mean values were compared using Holm-Sidak post hoc analysis. If an interaction was not found, the separated factors were analysed (marginal data). A χ<sup>2</sup> test was used to evaluate mortality between infarcted animals. One-factor ANOVA was used to analyze infarction size in infarcted groups. Differences were to be considered statistically significant if <italic>P</italic>&lt;0.05. Graphs and statistical analyses were performed using SigmaPlot for Windows version 12.0 (Systat Software Inc. San Jose, CA).</p>
</sec>
</sec>
<sec id="sec016" sec-type="results">
<title>Results</title>
<sec id="sec017">
<title>Survival, food intake, body weight and systolic arterial pressure</title>
<p>The mortality rate within 48 hours after infarction was 43%. No death in the Sham animals was observed. In the infarcted groups, two animals in both the IR0 and IR02 groups died, and one animal in the IR002 group died (p = 0.765). No difference was observed in infarction size between infarcted groups (<xref ref-type="table" rid="pone.0177521.t001">Table 1</xref>).</p>
<table-wrap id="pone.0177521.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0177521.t001</object-id>
<label>Table 1</label> <caption><title>Food intake, body weight, infarction size, echocardiographic and morphometric studies in Sham and infarcted rats with and without rosemary supplementation.</title></caption>
<alternatives>
<graphic id="pone.0177521.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0177521.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center"/>
<th align="center" colspan="3">SHAM groups</th>
<th align="center" colspan="3">Myocardial infarction groups</th>
<th align="center" colspan="3">p values</th>
</tr>
<tr>
<th align="center"/>
<th align="center">SR0</th>
<th align="center">SR002</th>
<th align="center">SR02</th>
<th align="center">IR0</th>
<th align="center">IR002</th>
<th align="center">IR02</th>
<th align="center">p (I)</th>
<th align="center">p (R)</th>
<th align="center">p (IxR)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center"><bold>Food intake (g)</bold></td>
<td align="center">25.8±0.2</td>
<td align="center">24.6±0.2</td>
<td align="center">25.7±0.2</td>
<td align="center">25.4±0.2</td>
<td align="center">25.0±0.2</td>
<td align="center">25.5±0.2</td>
<td align="center">0.187</td>
<td align="center">0.101</td>
<td align="center">0.143</td>
</tr>
<tr>
<td align="center"><bold>Weight gain (g)</bold></td>
<td align="center">143±8.2</td>
<td align="center">157±8.0</td>
<td align="center">148±8.6</td>
<td align="center">152±8.8</td>
<td align="center">156±8.8</td>
<td align="center">159±10</td>
<td align="center">0.385</td>
<td align="center">0.552</td>
<td align="center">0.773</td>
</tr>
<tr>
<td align="center"><bold>Infarction size (%)</bold></td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">41.9±4.5</td>
<td align="center">40.1±4.2</td>
<td align="center">43.6±4,7</td>
<td align="center">-</td>
<td align="center">0.244</td>
<td align="center">-</td>
</tr>
<tr>
<td align="center"><bold>LVDD/BW (mm/kg)</bold></td>
<td align="center">17.9±0.41</td>
<td align="center">17.1±0.39</td>
<td align="center">17.9±0.29</td>
<td align="center">24.6±0.74</td>
<td align="center">24.2±0.68</td>
<td align="center">24.1±0.93</td>
<td align="center"><bold>&lt;0.001</bold></td>
<td align="center">0.504</td>
<td align="center">0.582</td>
</tr>
<tr>
<td align="center"><bold>E wave (cm/s)</bold></td>
<td align="center">75.7±1.5</td>
<td align="center">77.2±2.1</td>
<td align="center">78.9±1.8</td>
<td align="center">98.4±5.5</td>
<td align="center">87.5±8.5</td>
<td align="center">92.7±9.4</td>
<td align="center"><bold>0.014</bold></td>
<td align="center">0.482</td>
<td align="center">0.246</td>
</tr>
<tr>
<td align="center"><bold>Diastolic area (mm</bold><sup><bold>2</bold></sup><bold>)</bold></td>
<td align="center">44.4±1.6</td>
<td align="center">44.5±1.8</td>
<td align="center">43.3±1.6</td>
<td align="center">92.2±3.9</td>
<td align="center">91.7±6.9</td>
<td align="center">85.2±4.5</td>
<td align="center"><bold>&lt;0.001</bold></td>
<td align="center">0.359</td>
<td align="center">0.557</td>
</tr>
<tr>
<td align="center"><bold>FAC (%)</bold></td>
<td align="center">73.3±0.9</td>
<td align="center">74.3±1.2</td>
<td align="center">75.6±1.0</td>
<td align="center">27.0±2.3</td>
<td align="center">28.2±1.5</td>
<td align="center">27.2±3.5</td>
<td align="center"><bold>&lt;0.001</bold></td>
<td align="center">0.697</td>
<td align="center">0.757</td>
</tr>
<tr>
<td align="center"><bold>Ejection fraction</bold></td>
<td align="center">0.91±0.01</td>
<td align="center">0.92±0.01</td>
<td align="center">0.93±0.01</td>
<td align="center">0.47±0.02</td>
<td align="center">0.49±0.02</td>
<td align="center">0.46±0.02</td>
<td align="center"><bold>&lt;0.001</bold></td>
<td align="center">0.571</td>
<td align="center">0.612</td>
</tr>
<tr>
<td align="center"><bold>E/E’ ratio</bold></td>
<td align="center">19.1±0.6</td>
<td align="center">19.6±0.9</td>
<td align="center">18.8±0.6</td>
<td align="center">24.4±1.7</td>
<td align="center">25.6±2.8</td>
<td align="center">23.6±2.6</td>
<td align="center"><bold>&lt;0.001</bold></td>
<td align="center">0.898</td>
<td align="center">0.523</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>I: infarction; S: Sham; R: Rosemary; R0: no supplementation; R002: 0.02% of rosemary supplementation; R02: 0.2% of rosemary supplementation; Weight gain: Final body weight–initial body weight (g); BW: body weight; LVDD/BW: left ventricular diastolic diameter indexed for body weight; E wave: peak velocity of early ventricular filling; FAC: fractional area change; E/E’ ratio: early diastolic mitral inflow velocity to early mitral annular velocity ratio. Data are expressed as the mean ± SEM. Bold numbers represent the significant effects that were considered.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>No difference was observed for food intake, weight gain (<xref ref-type="table" rid="pone.0177521.t001">Table 1</xref>) and systolic arterial pressure (<xref ref-type="fig" rid="pone.0177521.g002">Fig 2D</xref>) among all groups.</p>
<fig id="pone.0177521.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0177521.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Echocardiographic study and blood systolic pressure in Sham and infarcted rats with and without rosemary supplementation.</title>
<p>A. LA/BW: left atrial diameter indexed for body weight (p = 0.001); B. LA/AO: left atrial diameter indexed for aortic diameter (p = 0.024); C. EDT: E wave deceleration time (p = 0.004); D. BP: blood systolic pressure (p = 0.343). Data are expressed as the mean ± SEM. Asterisks (*) represent significant difference between groups (p&lt;0.05). Sample size: SR0 = 23; SR002 = 23; SR02 = 22; IR0 = 13; IR002 = 8; and IR02 = 9.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0177521.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec018">
<title>Effect of MI in rat hearts</title>
<p>MI led to adverse cardiac remodeling. Regarding morphological data, MI led to higher left ventricular end-diastolic diameter adjusted for body weight, higher diastolic area (<xref ref-type="table" rid="pone.0177521.t001">Table 1</xref>) and higher left atrium (<xref ref-type="fig" rid="pone.0177521.g002">Fig 2A and 2B</xref>), CSA (<xref ref-type="fig" rid="pone.0177521.g003">Fig 3A and 3B</xref>) and percentage of collagen (<xref ref-type="fig" rid="pone.0177521.g003">Fig 3C and 3D</xref>). MI impaired diastolic heart function, as shown by increased shorter E wave deceleration time (EDT) (<xref ref-type="fig" rid="pone.0177521.g002">Fig 2C</xref>) and increased E/E' ratio (<xref ref-type="table" rid="pone.0177521.t001">Table 1</xref>), and systolic function showed by lower fractional area change (<xref ref-type="table" rid="pone.0177521.t001">Table 1</xref>).</p>
<fig id="pone.0177521.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0177521.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Morphometric study in Sham and infarcted rats with and without rosemary supplementation.</title>
<p>A. CSA: cardiomyocyte cross-sectional area (p&lt;0.001); B. Microscopic images of CSA H&amp;E stained (evidenced with arrows) of groups SR0, IR0, IR002 and IR02; C. % collagen: p = 0.035; D. Microscopic images of myocytes Picrosirius red stained for collagen (red marks in images) of SR0, IR0, IR002 and IR02. Data are expressed as the mean ± SEM. Asterisks (*) represent significant difference between groups (p&lt;0.05). Sample size: SR0 = 23; SR002 = 23; SR02 = 22; IR0 = 13; IR002 = 8; and IR02 = 9.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0177521.g003" xlink:type="simple"/>
</fig>
<p>A greater oxidation of carbohydrates and impaired energy metabolism was observed as shown by higher activity of LDH (<xref ref-type="fig" rid="pone.0177521.g004">Fig 4A</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s006">S2 Table</xref>) and ATP synthase (<xref ref-type="fig" rid="pone.0177521.g004">Fig 4C</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s006">S2 Table</xref>), and lower activity of CS (<xref ref-type="fig" rid="pone.0177521.g004">Fig 4D</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s006">S2 Table</xref>) and Complex I (<xref ref-type="fig" rid="pone.0177521.g004">Fig 4E</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s006">S2 Table</xref>). MI also increased oxidative stress, as presented with higher LH concentration (<xref ref-type="fig" rid="pone.0177521.g005">Fig 5A</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s006">S2 Table</xref>) and SOD activity (<xref ref-type="fig" rid="pone.0177521.g005">Fig 5B</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s006">S2 Table</xref>), lower GSH-Px activity (<xref ref-type="fig" rid="pone.0177521.g005">Fig 5C</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s007">S3 Table</xref>), and lower expression of Nrf-2 (<xref ref-type="fig" rid="pone.0177521.g006">Fig 6A and 6B</xref>). No difference was observed for HO-1 (<xref ref-type="supplementary-material" rid="pone.0177521.s003">S3 Table</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s001">S1 Fig</xref>) and PGC-1α expression (<xref ref-type="supplementary-material" rid="pone.0177521.s003">S3 Table</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s002">S2 Fig</xref>).</p>
<fig id="pone.0177521.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0177521.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Energy metabolism enzymes in Sham and infarcted rats with and without rosemary supplementation.</title>
<p>LDH activity: lactate dehydrogenase activity (p = 0.014); CS activity: citrate synthase activity (p&lt;0.001); OHADH activity: 3-hydroxyacyl coenzyme-A dehydrogenase activity (p&lt;0.001); ATP sinthase activity (p = 0.039); Complex I activity: p = 0.004; Complex II activity: p&lt;0.001. Data are expressed as the mean ± SEM. Asterisks (*) represent significant difference between groups (P&lt;0.05). Sample size: SR0 = 8; SR002 = 8; SR02 = 8; IR0 = 10; IR002 = 7; and IR02 = 8.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0177521.g004" xlink:type="simple"/>
</fig>
<fig id="pone.0177521.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0177521.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Oxidative stress enzymes in Sham and infarcted rats with and without rosemary supplementation.</title>
<p>LH: lipid hydroperoxide concentration (p&lt;0.001); SOD activity: superoxide dismutase activity (p&lt;0.001); GSH-Px activity: glutathione peroxidase activity (p = 0.031). Data are expressed as the mean ± SEM. Asterisks (*) represent significant difference between groups (P&lt;0.05). Sample size: SR0 = 8; SR002 = 8; SR02 = 8; IR0 = 10; IR002 = 7; and IR02 = 8.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0177521.g005" xlink:type="simple"/>
</fig>
<fig id="pone.0177521.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0177521.g006</object-id>
<label>Fig 6</label>
<caption>
<title>Nrf2 expression in Sham and infarcted rats by Western blot.</title>
<p>A. Nrf2 expression; B. representative western blot of Nrf2 expression. Nrf2: nuclear erithroid factor 2; GAPDH glyceraldehyde-3-phosphate dehydrogenase. Since no interaction between factors was observed, the effect of myocardial infarction is represented. Data are expressed as the mean ± SEM. Asterisks (*) represent significant difference between groups. Sample size: SR0 = 10; SR002 = 10; SR02 = 10; IR0 = 10; IR002 = 8; and IR02 = 9.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0177521.g006" xlink:type="simple"/>
</fig>
<p>Higher intermediate and total MMP-2 activity (<xref ref-type="supplementary-material" rid="pone.0177521.s004">S4 Table</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s003">S3 Fig</xref>), lower IL-10, TNF-α and INF-γ concentration (<xref ref-type="supplementary-material" rid="pone.0177521.s008">S4 Table</xref>), and lower Bcl2 expression (<xref ref-type="supplementary-material" rid="pone.0177521.s008">S4 Table</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s004">S4 Fig</xref>) was observed after MI. No difference was observed for caspase-3 expression (<xref ref-type="supplementary-material" rid="pone.0177521.s008">S4 Table</xref>).</p>
</sec>
<sec id="sec019">
<title>Effect of rosemary supplementation after MI</title>
<p>Rosemary supplementation improved diastolic function (lower left atrial diameter [<xref ref-type="fig" rid="pone.0177521.g002">Fig 2A and 2B</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s005">S1 Table</xref>] and higher EDT [<xref ref-type="fig" rid="pone.0177521.g002">Fig 2C</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s005">S1 Table</xref>]) and reduced hypertrophy (<xref ref-type="fig" rid="pone.0177521.g003">Fig 3A</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s005">S1 Table</xref>) after MI.</p>
<p>Morphologic and functional changes were accompanied by increased β-oxidation of fatty acids, reduced lactate oxidation and improved respiratory chain activity, as shown by lower LDH activity (<xref ref-type="fig" rid="pone.0177521.g004">Fig 4A</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s006">S2 Table</xref>), and higher CS (<xref ref-type="fig" rid="pone.0177521.g004">Fig 4C</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s006">S2 Table</xref>), OHADH (<xref ref-type="fig" rid="pone.0177521.g004">Fig 4E</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s006">S2 Table</xref>), ATP synthase (<xref ref-type="fig" rid="pone.0177521.g004">Fig 4B</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s006">S2 Table</xref>) and Complex I (<xref ref-type="fig" rid="pone.0177521.g004">Fig 4D</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s006">S2 Table</xref>) activities. Rosemary supplementation also decreased oxidative stress, with lower concentration of LH (<xref ref-type="fig" rid="pone.0177521.g005">Fig 5A</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s006">S2 Table</xref>) and SOD activity (<xref ref-type="fig" rid="pone.0177521.g005">Fig 5B</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s006">S2 Table</xref>). No differences were observed for GSH-Px (<xref ref-type="fig" rid="pone.0177521.g005">Fig 5C</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s006">S2 Table</xref>) and catalase (<xref ref-type="supplementary-material" rid="pone.0177521.s005">S1 Table</xref>) activities, and Nrf-2, HO-1 and PGC-1α expression (<xref ref-type="supplementary-material" rid="pone.0177521.s007">S3 Table</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s003">S3 Fig</xref>).</p>
<p>Differences among the doses were also observed in diastolic function and hypertrophy. Group IR002 presented lower left atrium (<xref ref-type="fig" rid="pone.0177521.g002">Fig 2A and 2B</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s005">S1 Table</xref>) and CSA (<xref ref-type="fig" rid="pone.0177521.g003">Fig 3A</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s005">S1 Table</xref>). Group IR02 presented higher Complex II activity (<xref ref-type="fig" rid="pone.0177521.g004">Fig 4F</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s006">S2 Table</xref>).</p>
<p>No difference was observed for percentage of collagen with rosemary supplementation (<xref ref-type="fig" rid="pone.0177521.g003">Fig 3B</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s005">S1 Table</xref>), cytokines concentration, MMP-2 activity (<xref ref-type="supplementary-material" rid="pone.0177521.s004">S4 Table</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s003">S3 Fig</xref>), caspase-3 and Bcl2 expression (<xref ref-type="supplementary-material" rid="pone.0177521.s004">S4 Table</xref> and <xref ref-type="supplementary-material" rid="pone.0177521.s004">S4 Fig</xref>).</p>
</sec>
</sec>
<sec id="sec020" sec-type="conclusions">
<title>Discussion</title>
<p>The aim of the present study was to analyze the influence of rosemary supplementation of rat chow on adverse cardiac remodeling after myocardial infarction. Cardiac remodeling has significant clinical relevance as it can lead to complex changes in ventricular architecture, potentially evolving into chronic heart failure [<xref ref-type="bibr" rid="pone.0177521.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0177521.ref040">40</xref>]. For this reason, several strategies have been used to mitigate this process, including compounds found in rosemary leaves[<xref ref-type="bibr" rid="pone.0177521.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0177521.ref041">41</xref>]. It is well known that lifestyle factors, including nutrition, play a key role in the etiology of Cardiovascular Diseases (CVD), evidencing the importance to promote health diet including selected foods rather than individual nutrients[<xref ref-type="bibr" rid="pone.0177521.ref023">23</xref>, <xref ref-type="bibr" rid="pone.0177521.ref042">42</xref>]. In this context, the use of rosemary leaves instead of one isolated compound might lead to a synergistic effect, since adjuvant substances in the plant might enhance the activity of benefic components[<xref ref-type="bibr" rid="pone.0177521.ref043">43</xref>]. To our knowledge, this is the first study that assessed the supplementation with whole rosemary leaves on the morphology and function of the infarcted heart.</p>
<p>Myocardial infarction in the rat is an ideal model to study adverse cardiac remodeling post-infarction[<xref ref-type="bibr" rid="pone.0177521.ref044">44</xref>]. Cardiac remodeling can be defined as molecular, cellular, and interstitial modifications that are clinically manifested as changes in size, mass, geometry and heart function after cardiac injury. Heart dysfunction is the final sign of cardiac remodeling and is an important prognostic factor after MI, increasing the risk of death[<xref ref-type="bibr" rid="pone.0177521.ref045">45</xref>, <xref ref-type="bibr" rid="pone.0177521.ref046">46</xref>]. Diastolic dysfunction after MI refers to mechanical and functional abnormalities during relaxation and filling of the LV and is associated with hypertrophy and increased LA[<xref ref-type="bibr" rid="pone.0177521.ref047">47</xref>]. In the present study, rosemary supplementation after MI improved diastolic function, LV hypertrophy and LA diameters, evidencing the protective effect of rosemary leaves in the heart. Our results are in accordance with previous studies describing improved cardiac function in cardiac injury models by doxorubicin and ischemia/reperfusion after treatment with compounds found in rosemary[<xref ref-type="bibr" rid="pone.0177521.ref048">48</xref>, <xref ref-type="bibr" rid="pone.0177521.ref049">49</xref>].</p>
<p>The improvement of hypertrophy and diastolic function observed after rosemary intake was associated with changes in energy metabolism and decreased oxidative stress after MI in the present study. As clinical manifestations can be the result of changes to the heart’s cellular and molecular components[<xref ref-type="bibr" rid="pone.0177521.ref003">3</xref>], energy metabolism and antioxidant pathways could represent the mechanisms of action of rosemary leaves supplementation. In injury situations such as MI, the preferential use of fatty acids that are observed in the normal hearts may be shifted for glucose use[<xref ref-type="bibr" rid="pone.0177521.ref050">50</xref>, <xref ref-type="bibr" rid="pone.0177521.ref051">51</xref>]. In this case, the heart starts to form large amounts of lactate, increasing anaerobic metabolism of carbohydrates and LDH activity[<xref ref-type="bibr" rid="pone.0177521.ref052">52</xref>, <xref ref-type="bibr" rid="pone.0177521.ref053">53</xref>]. Rosemary supplementation after MI led to higher fatty acid oxidation and respiratory chain improvement, similar to the energy metabolism of normal hearts.</p>
<p>In addition to metabolic changes, oxidative stress and redox signaling are important contributors to cardiac remodeling[<xref ref-type="bibr" rid="pone.0177521.ref054">54</xref>]. Increased oxidative stress and cardiac oxidation has also been associated with diastolic dysfunction[<xref ref-type="bibr" rid="pone.0177521.ref047">47</xref>]. The toxic effects of ROS can be prevented in part by the antioxidant enzyme system including GSH-Px, SOD and catalase[<xref ref-type="bibr" rid="pone.0177521.ref055">55</xref>]. SOD is considered the first line of defense in protecting the mitochondria against deleterious effects of increased superoxide production, as described in cardiac remodeling and HF[<xref ref-type="bibr" rid="pone.0177521.ref056">56</xref>] and observed in the present study. Our results showed that rosemary supplementation decreased oxidative stress, which is in agreement with previous studies reporting antioxidant effect of rosemary and its compounds[<xref ref-type="bibr" rid="pone.0177521.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0177521.ref019">19</xref>, <xref ref-type="bibr" rid="pone.0177521.ref057">57</xref>]. Rosemary can mimic SOD by removing superoxide radicals[<xref ref-type="bibr" rid="pone.0177521.ref058">58</xref>], which could also explain the lower enzyme activity in cardiac tissue of the supplemented groups. No effect of rosemary was observed on Nrf-2 and HO-1 expression, different from what we expected and from previous reports showing Nrf2 activation after treatment with rosemary compounds[<xref ref-type="bibr" rid="pone.0177521.ref059">59</xref>, <xref ref-type="bibr" rid="pone.0177521.ref060">60</xref>]. One possible explanation is that in some pathological situations, as in hypoxia, Nrf-2 does not increase. Regulatory mechanisms such as the E3 ubiquitin (Siah2) protein ligase 2, which is activated in hypoxia, binds to Nrf-2 and increases its degradation, preventing it from acting on AREs and increasing the expression of antioxidant proteins[<xref ref-type="bibr" rid="pone.0177521.ref061">61</xref>].</p>
<p>In the present study, rosemary doses led to different effect in heart diastolic function and hypertrophy, similar to a J-shape response. The smallest dose of rosemary supplementation caused greater improvement in post-MI heart function. [<xref ref-type="bibr" rid="pone.0177521.ref062">62</xref>]. Forman and collaborators (2014) describes that antioxidants in fruits and vegetables maintain a cellular defense and adaptation response. The authors exemplifies that supplementation of phytochemicals to levels that exceed saturation of the antioxidant system will hardly exert any beneficial effect, by a mechanism that can be called “para-hormesis”[<xref ref-type="bibr" rid="pone.0177521.ref062">62</xref>]. In the present study, 0.2% of rosemary supplementation led to a greater antioxidant response (lower LH and higher antioxidant enzymes activities) which could impair the cellular healthy response signaling by ROS[<xref ref-type="bibr" rid="pone.0177521.ref063">63</xref>]. Also our finding of higher Complex II after 0.2% rosemary supplementation could indicate the para-hormesis mechanism. In the mithocondria, Complex II is part of the antioxidant system by controlling the ubiquinone pool and superoxide scavenging activity of the respiratory chain (RC). Complex II might also be activated upon reduction of the RC[<xref ref-type="bibr" rid="pone.0177521.ref064">64</xref>]. So in the present study, the supplementation with the highest dose of rosemary might have lost the protective effect exhibited with 0.02% of rosemary.</p>
<p>The limitation of the present study lies in its experimental type, not allowing us to extrapolate the findings to humans. However, it is important to highlight the clinical relevance of the results described. Our findings support further investigations of rosemary use as adjuvant therapy in adverse cardiac remodeling. Regarding rosemary dose in the present study, 0.02% and 0.2% in the rat chow is equivalent to 11 mg/day and 110 mg/day in humans, respectively[<xref ref-type="bibr" rid="pone.0177521.ref065">65</xref>].</p>
<p>In conclusion, dietary rosemary supplementation attenuated adverse cardiac remodeling caused by myocardial infarction in rats. The mechanism could involve improved energy metabolism and reduced oxidative stress. Rosemary supplementation may serve as a promising approach to attenuate adverse cardiac remodeling after MI.</p>
</sec>
<sec id="sec021">
<title>Supporting information</title>
<supplementary-material id="pone.0177521.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0177521.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Western blot for HO-1 adjusted by glyceraldehyde-3-phosphate dehydrogenase (GAPDH).</title>
<p>I: infarction; S: Sham; R: Rosemary; R0: no supplementation; R002: 0.02% of rosemary supplementation; R02: 0.2% of rosemary supplementation. Sample size: SR0 = 10; SR002 = 10; SR02 = 10; IR0 = 10; IR002 = 8; and IR02 = 9.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0177521.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0177521.s002" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Western blot for PGC1-α adjusted by glyceraldehyde-3-phosphate dehydrogenase (GAPDH).</title>
<p>I: infarction; S: Sham; R: Rosemary; R0: no supplementation; R002: 0.02% of rosemary supplementation; R02: 0.2% of rosemary supplementation. Sample size: SR0 = 10; SR002 = 10; SR02 = 10; IR0 = 10; IR002 = 8; and IR02 = 9.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0177521.s003" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0177521.s003" xlink:type="simple">
<label>S3 Fig</label>
<caption>
<title>Zimography picture of metalloproteinase-2 (72 kDa).</title>
<p>I: infarction; S: Sham; R: Rosemary; R0: no supplementation; R002: 0.02% of rosemary supplementation; R02: 0.2% of rosemary supplementation. Sample size: SR0 = 10; SR002 = 10; SR02 = 10; IR0 = 5; IR002 = 5; and IR02 = 4.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0177521.s004" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0177521.s004" xlink:type="simple">
<label>S4 Fig</label>
<caption>
<title>Western blot for Bcl-2 and Caspase-3 adjusted by glyceraldehyde-3-phosphate dehydrogenase (GAPDH).</title>
<p>I: infarction; S: Sham; R: Rosemary; R0: no supplementation; R002: 0.02% of rosemary supplementation; R02: 0.2% of rosemary supplementation. Sample size: SR0 = 10; SR002 = 10; SR02 = 10; IR0 = 10; IR002 = 8; and IR02 = 9.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0177521.s005" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pone.0177521.s005" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Food intake, body weight, infarction size, echocardiographic and morphometric studies in Sham and infarcted rats with and without rosemary supplementation.</title>
<p>I: infarction; S: Sham; R: Rosemary; R0: no supplementation; R002: 0.02% of rosemary supplementation; R02: 0.2% of rosemary supplementation; BW: body weight; LVDD/BW: left ventricular diastolic diameter indexed for body weight; AO: aortic diameter; LA: left atrial diameter; LA/BW: left atrial diameter indexed for body weight; LA/AO: left atrial diameter indexed for aortic diameter; E wave: peak velocity of early ventricular filling; FAC: fractional area change; EDT: E wave deceleration time; E/E’ ratio: early diastolic mitral inflow velocity to early mitral annular velocity ratio; CSA: cardiomyocyte cross-sectional area. Data are expressed as the mean ± SEM. Bold numbers represent the significant effects that were considered. *IxR: when interactions are observed, same superscript letters represent differences (p&lt;0.05) in a row (a = IR0≠SR0; b = IR002≠SR002; c = IR02≠SR02; A = IR0≠IR002; B = IR002≠IR02; C = IR0≠IR02). Sample size: SR0 = 10; SR002 = 10; SR02 = 10; IR0 = 10; IR002 = 8; and IR02 = 9.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0177521.s006" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pone.0177521.s006" xlink:type="simple">
<label>S2 Table</label>
<caption>
<title>Energy metabolism and oxidative stress enzymes in Sham and infarcted rats with and without rosemary supplementation.</title>
<p>I: infarction; S: Sham; R: Rosemary; R0: no supplementation; R002: 0.02% of rosemary supplementation; R02: 0.2% of rosemary supplementation; LDH activity: lactate dehydrogenase activity (nmol/mg protein); PIDH activity: pyruvate dehydrogenase activity; CS activity: citrate synthase activity; OHADH activity: 3-hydroxyacyl coenzyme-A dehydrogenase activity; ATP sinthase activity; Complex I activity; Complex II activity; LH: lipid hydroperoxide concentration; SOD activity: superoxide dismutase activity; GSH-Px activity: glutathione peroxidase activity. Data are expressed as the mean ± SEM. Bold numbers represent the significant effects that were considered. *IxR: when interactions are observed, same superscript letters represent differences (p&lt;0.05) in a row (a = SR0≠IR0; b = SR002≠IR002; c = IR02≠SR02; A = IR0≠IR002; B = IR002≠IR02; C = IR0≠IR02). Sample size: SR0 = 8; SR002 = 8; SR02 = 8; IR0 = 10; IR002 = 7; and IR02 = 8.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0177521.s007" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pone.0177521.s007" xlink:type="simple">
<label>S3 Table</label>
<caption>
<title>Nrf2, HO-1 and PGC1-a expression in Sham and infarcted rats with and without rosemary supplementation by Western blot.</title>
<p>I: infarction; S: Sham; R: Rosemary; R0: no supplementation; R002: 0.02% of rosemary supplementation; R02: 0.2% of rosemary supplementation; Nrf-2: nuclear erithroid factor 2; HO-1: heme-oxygenase-1; PGC1α: peroxisome proliferator-activated receptor-α coactivator. Data are expressed as the mean ± SEM. Bold numbers represent the significant effects that were considered. Sample size: SR0 = 10; SR002 = 10; SR02 = 10; IR0 = 10; IR002 = 8; and IR02 = 9.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0177521.s008" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pone.0177521.s008" xlink:type="simple">
<label>S4 Table</label>
<caption>
<title>TIMP-1, MMP-2 activity, cytokines and apoptosis markers in Sham and infarcted rats with and without rosemary supplementation.</title>
<p>I: infarction; S: Sham; R: Rosemary; R0: no supplementation; R002: 0.02% of rosemary supplementation; R02: 0.2% of rosemary supplementation; PFK activity: Phosphofructokinase activity; TIMP-1: Metaloprotease inhibitor-1; MMP-2: metaloprotease-2; IL-10: interleukin-10; ICAM-1: intercellular adhesion mollecule-1; TNF-α: tumor necrosis factor-α; INF-γ: interferon-γ. Data are expressed as mean ± SEM. Bold numbers represents significant effects considered. Sample size: SR0 = 10; SR002 = 10; SR02 = 10; IR0 = 10; IR002 = 8; and IR02 = 9.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank Mario B. Bruno, José Georgette, Antonio Carlos de Lalla, Elenize Jamas, and Corina Corrêa for animal management and technical assistance.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0177521.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mozaffarian</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Benjamin</surname> <given-names>EJ</given-names></name>, <name name-style="western"><surname>Go</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Arnett</surname> <given-names>DK</given-names></name>, <name name-style="western"><surname>Blaha</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Cushman</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Heart disease and stroke statistics—2015 update: a report from the American Heart Association</article-title>. <source>Circulation</source>. <year>2015</year>;<volume>131</volume>(<issue>4</issue>):<fpage>e29</fpage>–<lpage>322</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIR.0000000000000152" xlink:type="simple">10.1161/CIR.0000000000000152</ext-link></comment> <object-id pub-id-type="pmid">25520374</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zornoff</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Paiva</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Minicucci</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Spadaro</surname> <given-names>J</given-names></name>. <article-title>Experimental myocardium infarction in rats: analysis of the model</article-title>. <source>Arq Bras Cardiol</source>. <year>2009</year>;<volume>93</volume>:<fpage>434</fpage>–<lpage>40</lpage>. <object-id pub-id-type="pmid">19936465</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cohn</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Ferrari</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Sharpe</surname> <given-names>N</given-names></name>. <article-title>Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling</article-title>. <source>J Am Coll Cardiol</source>. <year>2000</year>;<volume>35</volume>:<fpage>569</fpage>–<lpage>82</lpage>. <object-id pub-id-type="pmid">10716457</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sun</surname> <given-names>Y</given-names></name>. <article-title>Myocardial repair/remodelling following infarction: roles of local factors</article-title>. <source>Cardiovasc Res</source>. <year>2009</year>;<volume>81</volume>:<fpage>482</fpage>–<lpage>90</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/cvr/cvn333" xlink:type="simple">10.1093/cvr/cvn333</ext-link></comment> <object-id pub-id-type="pmid">19050008</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhou</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Zheng</surname> <given-names>Y</given-names></name>. <article-title>The role of Nrf2-mediated pathway in cardiac remodeling and heart failure</article-title>. <source>Oxid Med Cell Logev</source>. <year>2014</year>;<volume>2014</volume>:<fpage>260429</fpage>.</mixed-citation></ref>
<ref id="pone.0177521.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hori</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nishida</surname> <given-names>K</given-names></name>. <article-title>Oxidative stress and left ventricular remodelling after myocardial infarction</article-title>. <source>Cardiovasc Res</source>. <year>2009</year>;<volume>81</volume>:<fpage>457</fpage>–<lpage>64</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/cvr/cvn335" xlink:type="simple">10.1093/cvr/cvn335</ext-link></comment> <object-id pub-id-type="pmid">19047340</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zornoff</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Paiva</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Minicucci</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Spadaro</surname> <given-names>J</given-names></name>. <article-title>Ventricular remodeling after myocardial infarction: concepts and clinical implications</article-title>. <source>Arq Bras Cardiol</source>. <year>2009</year>;<volume>92</volume>:<fpage>157</fpage>–<lpage>64</lpage>.</mixed-citation></ref>
<ref id="pone.0177521.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Punithavathi</surname> <given-names>VR</given-names></name>, <name name-style="western"><surname>Prince</surname> <given-names>PS</given-names></name>. <article-title>Pretreatment with a combination of quercetin and α-tocopherol ameliorates adenosine triphosphatases and lysosomal enzymes in myocardial infarcted rats</article-title>. <source>Life Sci</source>. <year>2010</year>;<volume>86</volume>:<fpage>178</fpage>–<lpage>84</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.lfs.2009.11.021" xlink:type="simple">10.1016/j.lfs.2009.11.021</ext-link></comment> <object-id pub-id-type="pmid">19958779</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Buttros</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Bergamaschi</surname> <given-names>CT</given-names></name>, <name name-style="western"><surname>Ribeiro</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Fracalossi</surname> <given-names>ACC</given-names></name>, <name name-style="western"><surname>Campos</surname> <given-names>RR</given-names></name>. <article-title>Cardioprotective actions of ascorbic acid during isoproterenol-induced acute myocardial infarction in rats</article-title>. <source>Pharmacology</source>. <year>2009</year>;<volume>84</volume>:<fpage>29</fpage>–<lpage>37</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1159/000222245" xlink:type="simple">10.1159/000222245</ext-link></comment> <object-id pub-id-type="pmid">19494560</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhu</surname> <given-names>YZ</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Tan</surname> <given-names>BK</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Whitemanb</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>YC</given-names></name>. <article-title>Antioxidants in Chinese herbal medicines: a biochemical perspective</article-title>. <source>Nat Prod Rep</source>. <year>2004</year>;<volume>21</volume>:<fpage>478</fpage>–<lpage>89</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1039/b304821g" xlink:type="simple">10.1039/b304821g</ext-link></comment> <object-id pub-id-type="pmid">15282631</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pérez-Fons</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Garzón</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>Micol</surname> <given-names>V</given-names></name>. <article-title>Relationship between the antioxidant capacity and effect of rosemary (Rosmarinus officinalis L.) polyphenols on membrane phospholipid order</article-title>. <source>J Agric Food Chem</source>. <year>2010</year>;<volume>58</volume>:<fpage>161</fpage>–<lpage>71</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/jf9026487" xlink:type="simple">10.1021/jf9026487</ext-link></comment> <object-id pub-id-type="pmid">19924866</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Genena</surname> <given-names>AK</given-names></name>, <name name-style="western"><surname>Hense</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Junior</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Souza</surname> <given-names>SM</given-names></name>. <article-title>Rosemary (Rosmarinus officinalis)–a study of the composition, antioxidant and antimicrobial activities of extracts obtained with supercritical carbon dioxide</article-title>. <source>Food Sci Tech</source>. <year>2008</year>;<volume>28</volume>:<fpage>463</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="pone.0177521.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bai</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>He</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Roller</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Lai</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Shao</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Pan</surname> <given-names>MH</given-names></name>, <etal>et al</etal>. <article-title>Flavonoids and phenolic compounds from Rosmarinus officinalis</article-title>. <source>Journal of agricultural and food chemistry</source>. <year>2010</year>;<volume>58</volume>(<issue>9</issue>):<fpage>5363</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/jf100332w" xlink:type="simple">10.1021/jf100332w</ext-link></comment> <object-id pub-id-type="pmid">20397728</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Scheckel</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Degner</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Romagnolo</surname> <given-names>D</given-names></name>. <article-title>Rosmarinic acid antagonizes activator protein-1-dependent activation of cyclooxygenase-2 expression in human cancer and nonmalignant cell lines</article-title>. <source>J Nutr</source>. <year>2008</year>;<volume>138</volume>:<fpage>2098</fpage>–<lpage>105</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3945/jn.108.090431" xlink:type="simple">10.3945/jn.108.090431</ext-link></comment> <object-id pub-id-type="pmid">18936204</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Karthik</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Viswanathan</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Anuradha</surname> <given-names>CV</given-names></name>. <article-title>Administration of rosmarinic acid reduces cardiopathology and blood pressure through inhibition of p22phox NADPH oxidase in fructose-fed hypertensive rats</article-title>. <source>J Cardiovasc Pharmacol</source>. <year>2011</year>;<volume>58</volume>(<issue>5</issue>):<fpage>514</fpage>–<lpage>21</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/FJC.0b013e31822c265d" xlink:type="simple">10.1097/FJC.0b013e31822c265d</ext-link></comment> <object-id pub-id-type="pmid">21795992</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haraguchi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Sait</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Okamura</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Yagi</surname> <given-names>A</given-names></name>. <article-title>Inhibition of lipid peroxidation and superoxide generation by diterpenoids from Rosmarinus officinalis</article-title>. <source>Planta Med</source>. <year>1995</year>;<volume>61</volume>:<fpage>333</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1055/s-2006-958094" xlink:type="simple">10.1055/s-2006-958094</ext-link></comment> <object-id pub-id-type="pmid">7480180</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peng</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Su</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Chyau</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Sung</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Ho</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Peng</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Supercritical fluid extracts of rosemary leaves exhibit potent anti-inflammation and anti-tumor effects</article-title>. <source>Biosci Biotechnol Biochem</source>. <year>2007</year>;<volume>71</volume>:<fpage>2223</fpage>–<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1271/bbb.70199" xlink:type="simple">10.1271/bbb.70199</ext-link></comment> <object-id pub-id-type="pmid">17827696</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lian</surname> <given-names>K-C</given-names></name>, <name name-style="western"><surname>Chuang</surname> <given-names>J-J</given-names></name>, <name name-style="western"><surname>Hsieh</surname> <given-names>C-W</given-names></name>, <name name-style="western"><surname>Wung</surname> <given-names>B-S</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>G-D</given-names></name>, <name name-style="western"><surname>Jian</surname> <given-names>T-Y</given-names></name>, <etal>et al</etal>. <article-title>Dual mechanisms of NF-κB inhibition in carnosol-treated endothelial cells</article-title>. <source>Toxicol Appl Pharm</source>. <year>2010</year>;<volume>245</volume>:<fpage>21</fpage>–<lpage>35</lpage>.</mixed-citation></ref>
<ref id="pone.0177521.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Posadas</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Caz</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Largo</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Gándara</surname> <given-names>BDl</given-names></name>, <name name-style="western"><surname>Matallanas</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Reglero</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Protective effect of supercritical fluid rosemary extract, Rosmarinus officinalis, on antioxidants of major organs of aged rats</article-title>. <source>Exp Gerontol</source>. <year>2009</year>;<volume>44</volume>:<fpage>383</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.exger.2009.02.015" xlink:type="simple">10.1016/j.exger.2009.02.015</ext-link></comment> <object-id pub-id-type="pmid">19289162</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Botsoglou</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Taitzoglou</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Zervos</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Botsoglou</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Tsantarliotou</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chatzopoulou</surname> <given-names>PS</given-names></name>. <article-title>Potential of long-term dietary administration of rosemary in improving the antioxidant status of rat tissues following carbon tetrachloride intoxication</article-title>. <source>Food Chem Toxicol</source>. <year>2010</year>;<volume>48</volume>(<issue>3</issue>):<fpage>944</fpage>–<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.fct.2010.01.004" xlink:type="simple">10.1016/j.fct.2010.01.004</ext-link></comment> <object-id pub-id-type="pmid">20060873</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Tian</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Meng</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Fu</surname> <given-names>F</given-names></name>. <article-title>Protective Effect of RA on Myocardial Infarction-Induced Cardiac Fibrosis via AT1R/p38 MAPK Pathway Signaling and Modulation of the ACE2/ACE Ratio</article-title>. <source>Journal of agricultural and food chemistry</source>. <year>2016</year>;<volume>64</volume>(<issue>35</issue>):<fpage>6716</fpage>–<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/acs.jafc.6b03001" xlink:type="simple">10.1021/acs.jafc.6b03001</ext-link></comment> <object-id pub-id-type="pmid">27538767</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Retelny</surname> <given-names>VS</given-names></name>, <name name-style="western"><surname>Neuendorf</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Roth</surname> <given-names>JL</given-names></name>. <article-title>Nutrition protocols for the prevention of cardiovascular disease</article-title>. <source>Nutr Clin Pract</source>. <year>2008</year>;<volume>23</volume>(<issue>5</issue>):<fpage>468</fpage>–<lpage>76</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/0884533608323425" xlink:type="simple">10.1177/0884533608323425</ext-link></comment> <object-id pub-id-type="pmid">18849551</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mozaffarian</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Appel</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Van Horn</surname> <given-names>L</given-names></name>. <article-title>Components of a cardioprotective diet: new insights</article-title>. <source>Circulation</source>. <year>2011</year>;<volume>123</volume>(<issue>24</issue>):<fpage>2870</fpage>–<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCULATIONAHA.110.968735" xlink:type="simple">10.1161/CIRCULATIONAHA.110.968735</ext-link></comment> <object-id pub-id-type="pmid">21690503</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref024"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Guide for the Care and Use of Laboratory Animals. Animals NRCUCftUotGftCaUoL, editor. Washington, DC: National Academies Press; 2011.</mixed-citation></ref>
<ref id="pone.0177521.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pfeffer</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Finn</surname> <given-names>PV</given-names></name>, <name name-style="western"><surname>Zornoff</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Pfeffer</surname> <given-names>MA</given-names></name>. <article-title>Endothelin-A receptor antagonism during acute myocardial infarction in rats</article-title>. <source>Cardiovasc Drugs Ther</source>. <year>2000</year>;<volume>14</volume>:<fpage>579</fpage>–<lpage>87</lpage>. <object-id pub-id-type="pmid">11300358</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Santos</surname> <given-names>PP</given-names></name>, <name name-style="western"><surname>Rafacho</surname> <given-names>BP</given-names></name>, <name name-style="western"><surname>Goncalves Ade</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Jaldin</surname> <given-names>RG</given-names></name>, <name name-style="western"><surname>Nascimento</surname> <given-names>TB</given-names></name>, <name name-style="western"><surname>Silva</surname> <given-names>MA</given-names></name>, <etal>et al</etal>. <article-title>Vitamin D induces increased systolic arterial pressure via vascular reactivity and mechanical properties</article-title>. <source>PLoS One</source>. <year>2014</year>;<volume>9</volume>:<fpage>e98895</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0098895" xlink:type="simple">10.1371/journal.pone.0098895</ext-link></comment> <object-id pub-id-type="pmid">24921930</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zornoff</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Matsubara</surname> <given-names>BB</given-names></name>, <name name-style="western"><surname>Matsubara</surname> <given-names>LS</given-names></name>, <name name-style="western"><surname>Azevedo</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Minicucci</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Campana</surname> <given-names>AO</given-names></name>, <etal>et al</etal>. <article-title>b-carotene supplementation results in adverse ventricular remodeling after acute myocardial infarction</article-title>. <source>Nutrition</source>. <year>2006</year>;<volume>22</volume>:<fpage>146</fpage>–<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.nut.2005.05.008" xlink:type="simple">10.1016/j.nut.2005.05.008</ext-link></comment> <object-id pub-id-type="pmid">16183256</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Paiva</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Novo</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Matsubara</surname> <given-names>BB</given-names></name>, <name name-style="western"><surname>Matsubara</surname> <given-names>LS</given-names></name>, <name name-style="western"><surname>Azevedo</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Minicucci</surname> <given-names>MF</given-names></name>, <etal>et al</etal>. <article-title>beta-carotene attenuates the paradoxical effect of tobacco smoke on the mortality of rats after experimental myocardial infarction</article-title>. <source>J Nutr</source>. <year>2005</year>;<volume>135</volume>(<issue>9</issue>):<fpage>2109</fpage>–<lpage>13</lpage>. <object-id pub-id-type="pmid">16140884</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lang</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Bierig</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Devereaux</surname> <given-names>RB</given-names></name>, <name name-style="western"><surname>Flachskampf</surname> <given-names>FA</given-names></name>, <name name-style="western"><surname>Foster</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Pellikka</surname> <given-names>PA</given-names></name>, <etal>et al</etal>. <article-title>Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology</article-title>. <source>J Am Soc Echocardiogr</source>. <year>2005</year>;<volume>18</volume>:<fpage>1440</fpage>–<lpage>63</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.echo.2005.10.005" xlink:type="simple">10.1016/j.echo.2005.10.005</ext-link></comment> <object-id pub-id-type="pmid">16376782</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Spadaro</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Fishbein</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hare</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Pfeffer</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Maroko</surname> <given-names>P</given-names></name>. <article-title>Characterization of myocardial infarcts in the rat</article-title>. <source>Arch Pathol Lab Med</source>. <year>1980</year>;<volume>104</volume>:<fpage>179</fpage>–<lpage>83</lpage>. <object-id pub-id-type="pmid">6892678</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Minicucci</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Azevedo</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Martinez</surname> <given-names>PF</given-names></name>, <name name-style="western"><surname>Lima</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Bonomo</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Guizoni</surname> <given-names>DM</given-names></name>, <etal>et al</etal>. <article-title>Critical infarct size to induce ventricular remodeling, cardiac dysfunction and heart failure in rats</article-title>. <source>Int J Cardiol</source>. <year>2011</year>;<volume>151</volume>:<fpage>242</fpage>–<lpage>3</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijcard.2011.06.068" xlink:type="simple">10.1016/j.ijcard.2011.06.068</ext-link></comment> <object-id pub-id-type="pmid">21719125</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Csonka</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kupai</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kocsis</surname> <given-names>GF</given-names></name>, <name name-style="western"><surname>Novak</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Fekete</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Bencsik</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Measurement of myocardial infarct size in preclinical studies</article-title>. <source>J Pharmacol Toxicol Methods</source>. <year>2010</year>;<volume>61</volume>:<fpage>163</fpage>–<lpage>70</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vascn.2010.02.014" xlink:type="simple">10.1016/j.vascn.2010.02.014</ext-link></comment> <object-id pub-id-type="pmid">20188845</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Paiva</surname> <given-names>SAR</given-names></name>, <name name-style="western"><surname>Zornoff</surname> <given-names>LAM</given-names></name>, <name name-style="western"><surname>Okoshi</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Okoshi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Matsubara</surname> <given-names>LS</given-names></name>, <name name-style="western"><surname>Matsubara</surname> <given-names>BB</given-names></name>, <etal>et al</etal>. <article-title>Ventricular remodeling induced by retinoic acid supplementation in adult rats</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2003</year>;<volume>284</volume>(<issue>6</issue>):<fpage>2242</fpage>–<lpage>6</lpage>.</mixed-citation></ref>
<ref id="pone.0177521.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goncalves</surname> <given-names>AF</given-names></name>, <name name-style="western"><surname>Congio</surname> <given-names>LH</given-names></name>, <name name-style="western"><surname>dos Santos</surname> <given-names>PP</given-names></name>, <name name-style="western"><surname>Rafacho</surname> <given-names>BP</given-names></name>, <name name-style="western"><surname>Pereira</surname> <given-names>BL</given-names></name>, <name name-style="western"><surname>Claro</surname> <given-names>RF</given-names></name>, <etal>et al</etal>. <article-title>Pamidronate attenuates diastolic dysfunction induced by myocardial infarction associated with changes in geometric patterning</article-title>. <source>Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology</source>. <year>2015</year>;<volume>35</volume>(<issue>1</issue>):<fpage>259</fpage>–<lpage>69</lpage>.</mixed-citation></ref>
<ref id="pone.0177521.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weber</surname> <given-names>KT</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Tyagi</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Cleutjens</surname> <given-names>JP</given-names></name>. <article-title>Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms</article-title>. <source>J Mol Cell Cardiol</source>. <year>1994</year>;<volume>26</volume>:<fpage>279</fpage>–<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1006/jmcc.1994.1036" xlink:type="simple">10.1006/jmcc.1994.1036</ext-link></comment> <object-id pub-id-type="pmid">8028011</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ewing</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Janero</surname> <given-names>DR</given-names></name>. <article-title>Microplate superoxide dismutase assay employing a nonenzymatic superoxide generator</article-title>. <source>Anal Biochem</source>. <year>1995</year>;<volume>232</volume>(<issue>2</issue>):<fpage>243</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1006/abio.1995.0014" xlink:type="simple">10.1006/abio.1995.0014</ext-link></comment> <object-id pub-id-type="pmid">8747482</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burneiko</surname> <given-names>RC</given-names></name>, <name name-style="western"><surname>Diniz</surname> <given-names>YS</given-names></name>, <name name-style="western"><surname>Galhardi</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Rodrigues</surname> <given-names>HG</given-names></name>, <name name-style="western"><surname>Ebaid</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Faine</surname> <given-names>LA</given-names></name>, <etal>et al</etal>. <article-title>Interaction of hypercaloric diet and physical exercise on lipid profile, oxidative stress and antioxidant defenses</article-title>. <source>Food Chem Toxicol</source>. <year>2006</year>;<volume>44</volume>(<issue>7</issue>):<fpage>1167</fpage>–<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.fct.2006.01.004" xlink:type="simple">10.1016/j.fct.2006.01.004</ext-link></comment> <object-id pub-id-type="pmid">16516366</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Assalin</surname> <given-names>HB</given-names></name>, <name name-style="western"><surname>Rafacho</surname> <given-names>BP</given-names></name>, <name name-style="western"><surname>dos Santos</surname> <given-names>PP</given-names></name>, <name name-style="western"><surname>Ardisson</surname> <given-names>LP</given-names></name>, <name name-style="western"><surname>Roscani</surname> <given-names>MG</given-names></name>, <name name-style="western"><surname>Chiuso-Minicucci</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Impact of the Length of Vitamin D Deficiency on Cardiac Remodeling</article-title>. <source>Circulation-Heart Failure</source>. <year>2013</year>;<volume>6</volume>(<issue>4</issue>):<fpage>809</fpage>–<lpage>16</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCHEARTFAILURE.112.000298" xlink:type="simple">10.1161/CIRCHEARTFAILURE.112.000298</ext-link></comment> <object-id pub-id-type="pmid">23709660</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lustosa</surname> <given-names>BB</given-names></name>, <name name-style="western"><surname>Polegato</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Minicucci</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rafacho</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Santos</surname> <given-names>PP</given-names></name>, <name name-style="western"><surname>Fernandes</surname> <given-names>AA</given-names></name>, <etal>et al</etal>. <article-title>Green tea (Cammellia sinensis) attenuates ventricular remodeling after experimental myocardial infarction</article-title>. <source>International journal of cardiology</source>. <year>2016</year>;<volume>225</volume>:<fpage>147</fpage>–<lpage>53</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijcard.2016.09.092" xlink:type="simple">10.1016/j.ijcard.2016.09.092</ext-link></comment> <object-id pub-id-type="pmid">27723532</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Idikio</surname> <given-names>HA</given-names></name>. <article-title>Postmyocardial infarct remodeling and heart failure: potential contributions from pro- and antiaging factors</article-title>. <source>Cardiol Res Pract</source>. <year>2011</year>;<volume>2011</volume>:<fpage>836806</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4061/2011/836806" xlink:type="simple">10.4061/2011/836806</ext-link></comment> <object-id pub-id-type="pmid">21559227</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cheung</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tai</surname> <given-names>J</given-names></name>. <article-title>Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis</article-title>. <source>Oncol Rep</source>. <year>2007</year>;<volume>17</volume>:<fpage>1525</fpage>–<lpage>31</lpage>. <object-id pub-id-type="pmid">17487414</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eilat-Adar</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Sinai</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Yosefy</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Henkin</surname> <given-names>Y</given-names></name>. <article-title>Nutritional recommendations for cardiovascular disease prevention</article-title>. <source>Nutrients</source>. <year>2013</year>;<volume>5</volume>(<issue>9</issue>):<fpage>3646</fpage>–<lpage>83</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/nu5093646" xlink:type="simple">10.3390/nu5093646</ext-link></comment> <object-id pub-id-type="pmid">24067391</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gilbert</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Alves</surname> <given-names>LF</given-names></name>. <article-title>Synergy in plant medicines</article-title>. <source>Current medicinal chemistry</source>. <year>2003</year>;<volume>10</volume>(<issue>1</issue>):<fpage>13</fpage>–<lpage>20</lpage>. <object-id pub-id-type="pmid">12570718</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pfeffer</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Pfeffer</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Fishbein</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Fletcher</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Spadaro</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Cloner</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Myocardial infarct size and ventricular function in rats</article-title>. <source>Circ Res</source>. <year>1979</year>;<volume>44</volume>:<fpage>503</fpage>–<lpage>12</lpage>. <object-id pub-id-type="pmid">428047</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Minicucci</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Farah</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Fusco</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Cogni</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Azevedo</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Okoshi</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Infarct Size as Predictor of Systolic Functional Recovery after Myocardial Infarction</article-title>. <source>Arquivos brasileiros de cardiologia</source>. <year>2014</year>;<volume>102</volume>(<issue>6</issue>):<fpage>549</fpage>–<lpage>56</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5935/abc.20140051" xlink:type="simple">10.5935/abc.20140051</ext-link></comment> <object-id pub-id-type="pmid">25004416</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Polegato</surname> <given-names>BF</given-names></name>, <name name-style="western"><surname>Minicucci</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Azevedo</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Gonçalves</surname> <given-names>AF</given-names></name>, <name name-style="western"><surname>Lima</surname> <given-names>AF</given-names></name>, <name name-style="western"><surname>Martinez</surname> <given-names>PF</given-names></name>, <etal>et al</etal>. <article-title>Association between Functional Variables and Heart Failure after Myocardial Infarction in Rats</article-title>. <source>Arquivos brasileiros de cardiologia</source>. <year>2016</year>;<volume>106</volume>(<issue>2</issue>):<fpage>105</fpage>–<lpage>12</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5935/abc.20160015" xlink:type="simple">10.5935/abc.20160015</ext-link></comment> <object-id pub-id-type="pmid">26815462</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jeong</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Dudley</surname> <given-names>SC</given-names> <suffix>Jr.</suffix></name> <article-title>Diastolic dysfunction</article-title>. <source>Circ J</source>. <year>2015</year>;<volume>79</volume>(<issue>3</issue>):<fpage>470</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1253/circj.CJ-15-0064" xlink:type="simple">10.1253/circj.CJ-15-0064</ext-link></comment> <object-id pub-id-type="pmid">25746522</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sadzuka</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Sugiyama</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Shimoi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kinae</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Hirota</surname> <given-names>S</given-names></name>. <article-title>Protective effect of flavonoids on doxorubicin-induced cardiotoxicity</article-title>. <source>Toxicol Lett</source>. <year>1997</year>;<volume>92</volume>:<fpage>1</fpage>–<lpage>7</lpage>. <object-id pub-id-type="pmid">9242351</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sun</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Gao</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Shen</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>:<fpage>e33491</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0033491" xlink:type="simple">10.1371/journal.pone.0033491</ext-link></comment> <object-id pub-id-type="pmid">22432030</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Saks</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Favier</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Guzun</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Schlattner</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Wallimann</surname> <given-names>T</given-names></name>. <article-title>Molecular system bioenergetics: regulation of substrate supply in response to heart energy demands</article-title>. <source>J Physiol</source>. <year>2006</year>;<volume>577</volume>:<fpage>769</fpage>–<lpage>77</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1113/jphysiol.2006.120584" xlink:type="simple">10.1113/jphysiol.2006.120584</ext-link></comment> <object-id pub-id-type="pmid">17008367</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stanley</surname> <given-names>WC</given-names></name>, <name name-style="western"><surname>Recchia</surname> <given-names>FA</given-names></name>, <name name-style="western"><surname>Lopaschuk</surname> <given-names>GD</given-names></name>. <article-title>Myocardial substrate metabolism in the normal and failing heart</article-title>. <source>Physiol Rev</source>. <year>2005</year>;<volume>85</volume>:<fpage>1093</fpage>–<lpage>129</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/physrev.00006.2004" xlink:type="simple">10.1152/physrev.00006.2004</ext-link></comment> <object-id pub-id-type="pmid">15987803</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nelly</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Morgan</surname> <given-names>HE</given-names></name>. <article-title>Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle</article-title>. <source>Ann Rev Physiol</source>. <year>1974</year>;<volume>36</volume>:<fpage>413</fpage>–<lpage>59</lpage>.</mixed-citation></ref>
<ref id="pone.0177521.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wolfe</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Sievers</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Visseren</surname> <given-names>FL</given-names></name>, <name name-style="western"><surname>Donnelly</surname> <given-names>TJ</given-names></name>. <article-title>Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment</article-title>. <source>Circulation</source>. <year>1993</year>;<volume>87</volume>:<fpage>881</fpage>–<lpage>92</lpage>. <object-id pub-id-type="pmid">8443909</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Madamanchi</surname> <given-names>NR</given-names></name>, <name name-style="western"><surname>Runge</surname> <given-names>MS</given-names></name>. <article-title>Redox signaling in cardiovascular health and disease</article-title>. <source>Free Radic Biol Med</source>. <year>2013</year>;<volume>61C</volume>:<fpage>473</fpage>–<lpage>501</lpage>.</mixed-citation></ref>
<ref id="pone.0177521.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van Deel</surname> <given-names>ED</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Oury</surname> <given-names>TD</given-names></name>, <etal>et al</etal>. <article-title>Extracellular SOD protects the heart against oxidative stress and hypertrophy after myocardial infarction</article-title>. <source>Free Radic Biol Med</source>. <year>2008</year>;<volume>44</volume>:<fpage>1305</fpage>–<lpage>13</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.freeradbiomed.2007.12.007" xlink:type="simple">10.1016/j.freeradbiomed.2007.12.007</ext-link></comment> <object-id pub-id-type="pmid">18206658</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Tran</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Phinney</surname> <given-names>BS</given-names></name>, <name name-style="western"><surname>Knowlton</surname> <given-names>AA</given-names></name>. <article-title>Mitochondrial proteome remodeling in ischemic heart failure</article-title>. <source>Life Sci</source>. <year>2014</year>;<volume>101</volume>:<fpage>27</fpage>–<lpage>36</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.lfs.2014.02.004" xlink:type="simple">10.1016/j.lfs.2014.02.004</ext-link></comment> <object-id pub-id-type="pmid">24548633</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tamaki</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Tabuchi</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kosaka</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Satoh</surname> <given-names>T</given-names></name>. <article-title>Activated glutathione metabolism participates in protective effects of carnosic acid against oxidative stress in neuronal HT22 cells</article-title>. <source>Planta Med</source>. <year>2010</year>;<volume>76</volume>:<fpage>683</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1055/s-0029-1240622" xlink:type="simple">10.1055/s-0029-1240622</ext-link></comment> <object-id pub-id-type="pmid">19941258</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chohan</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Naughton</surname> <given-names>DP</given-names></name>, <name name-style="western"><surname>Opara</surname> <given-names>EI</given-names></name>. <article-title>Determination of superoxide dismutase mimetic activity in common culinary herbs</article-title>. <source>SpringerPlus</source>. <year>2014</year>;<volume>3</volume>:<fpage>578</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/2193-1801-3-578" xlink:type="simple">10.1186/2193-1801-3-578</ext-link></comment> <object-id pub-id-type="pmid">25332878</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sun</surname> <given-names>GB</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ye</surname> <given-names>JX</given-names></name>, <name name-style="western"><surname>Si</surname> <given-names>JY</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>HB</given-names></name>, <etal>et al</etal>. <article-title>Oxidative stress suppression by luteolin-induced heme oxygenase-1 expression</article-title>. <source>Toxicol Appl Pharmacol</source>. <year>2012</year>;<volume>265</volume>:<fpage>229</fpage>–<lpage>40</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.taap.2012.10.002" xlink:type="simple">10.1016/j.taap.2012.10.002</ext-link></comment> <object-id pub-id-type="pmid">23051850</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sahu</surname> <given-names>BD</given-names></name>, <name name-style="western"><surname>Putcha</surname> <given-names>UK</given-names></name>, <name name-style="western"><surname>Kuncha</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rachamalla</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Sistla</surname> <given-names>R</given-names></name>. <article-title>Carnosic acid promotes myocardial antioxidant response and prevents isoproterenol-induced myocardial oxidative stress and apoptosis in mice</article-title>. <source>Mol Cell Biochem</source>. <year>2014</year>;<volume>394</volume>:<fpage>163</fpage>–<lpage>76</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11010-014-2092-5" xlink:type="simple">10.1007/s11010-014-2092-5</ext-link></comment> <object-id pub-id-type="pmid">24903830</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baba</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Morimoto</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Imaoka</surname> <given-names>S</given-names></name>. <article-title>Seven in absentia homolog 2 (Siah2) protein is a regulator of NF-E2-related factor 2 (Nrf2)</article-title>. <source>J Biol Chem</source>. <year>2013</year>;<volume>288</volume>(<issue>25</issue>):<fpage>18393</fpage>–<lpage>405</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M112.438762" xlink:type="simple">10.1074/jbc.M112.438762</ext-link></comment> <object-id pub-id-type="pmid">23645672</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Forman</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Davies</surname> <given-names>KJ</given-names></name>, <name name-style="western"><surname>Ursini</surname> <given-names>F</given-names></name>. <article-title>How do nutritional antioxidants really work: nucleophilic tone and para-hormesis versus free radical scavenging in vivo</article-title>. <source>Free Radic Biol Med</source>. <year>2014</year>;<volume>66</volume>:<fpage>24</fpage>–<lpage>35</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.freeradbiomed.2013.05.045" xlink:type="simple">10.1016/j.freeradbiomed.2013.05.045</ext-link></comment> <object-id pub-id-type="pmid">23747930</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ristow</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Schmeisser</surname> <given-names>K</given-names></name>. <article-title>Mitohormesis: Promoting Health and Lifespan by Increased Levels of Reactive Oxygen Species (ROS)</article-title>. <source>Dose-Response</source>. <year>2014</year>;<volume>12</volume>:<fpage>288</fpage>–<lpage>341</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2203/dose-response.13-035.Ristow" xlink:type="simple">10.2203/dose-response.13-035.Ristow</ext-link></comment> <object-id pub-id-type="pmid">24910588</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rustin</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Munnich</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Rötig</surname> <given-names>A</given-names></name>. <article-title>Succinate dehydrogenase and human diseases: new insights into a well-known enzyme</article-title>. <source>Eur J Hum Genet</source>. <year>2002</year>;<volume>10</volume>:<fpage>289</fpage>–<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.ejhg.5200793" xlink:type="simple">10.1038/sj.ejhg.5200793</ext-link></comment> <object-id pub-id-type="pmid">12082502</object-id></mixed-citation></ref>
<ref id="pone.0177521.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reagan-Shaw</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Nihal</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ahmad</surname> <given-names>N</given-names></name>. <article-title>Dose translation from animal to human studies revisited</article-title>. <source>FASEB J</source>. <year>2008</year>;<volume>22</volume>:<fpage>659</fpage>–<lpage>61</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1096/fj.07-9574LSF" xlink:type="simple">10.1096/fj.07-9574LSF</ext-link></comment> <object-id pub-id-type="pmid">17942826</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>